VANCOUVER, British Columbia, Sept. 15, 2020 (Globe NEWSWIRE) — AgraFlora Organics Intercontinental Inc. (“AgraFlora” or the “Company”) (CSE: AGRA) (Frankfurt: PU31) (OTCPK: AGFAF) is delighted to announce that its wholly owned subsidiary Farmako GmbH (“Farmako”) has executed the binding offer arrangement (the “Offer Agreement”) with ZenPharm Ltd (“ZenPharm”), a subsidiary of Zenabis Global Inc. (TSX: ZENA) (“Zenabis”).
Pursuant to the Source Agreement, ZenPharm will provide EU-GMP good quality clinical cannabis flower cultivated by Zenabis to Farmako for distribution to healthcare hashish sufferers in Germany. The arrangement is meant to facilitate the distribution of 1,500 kilograms of cannabis flower by Farmako in Germany in excess of a 3 12 months expression. Farmako will distribute the merchandise to its recognized community of German pharmacies. The products and solutions will have Farmako’s branding, an essential phase in constructing model consciousness and loyalty with doctors, pharmacists and clients. The items initially include high potency THC flower and balanced THC and CBD flower, two products classes that management thinks are in maximum demand from customers in Germany. Shipments to Farmako are envisioned to commence in November 2020.
Farmako CEO Katrin Eckmans stated: “It is our intention to build partnerships with reliable suppliers and ensure high excellent and sustainable provide at a truthful cost selection to German sufferers. ZenPharm and Zenabis have verified themselves as trustful and dependable supply associates. Our objective to offer sustainable merchandise for German individuals takes a large move ahead with this transaction, and my team is excitedly working on our item launch to occur later on this 12 months.”
About AgraFlora Organics Global Inc.
AgraFlora Organics Intercontinental Inc. is a primary hashish enterprise constructing shareholder value by means of the growth of income generating working belongings in the world wide cannabis marketplace. AgraFlora is centered mostly on the Canadian cannabis business the world’s most innovative and controlled legal hashish industry. Flagship Canadian property involve: Edibles & Infusions, a thoroughly automatic manufacturing facility in Winnipeg, MB for white-label and customer branded edible manufacturing Propagation Expert services Canada, a big-scale commercial greenhouse in Delta, BC concentrated on reshaping the Canadian flower industry with higher-potency, lower price cannabis flower, and AAA Heidelberg, a craft targeted hashish producer in London, ON. In addition, AgraFlora’s wholly owned subsidiary Farmako GmbH is scaling in direction of its goal of remaining Europe’s top distributor of professional medical cannabis. Farmako at this time has energetic distribution functions in Germany and expects to begin active operations in the United Kingdom in 2020. For additional information and facts you should go to: https://agraflora.com/.
About Farmako GmbH
Farmako GmbH is a pharmaceutical wholesaler dependent in Frankfurt, Germany. The organization focuses on the distribution of medical cannabis to pharmacies with the purpose of securing the offer for hashish sufferers and closing the gap concerning supply and demand from customers for professional medical hashish. Farmako is organizing to extend its enterprise product into other European international locations with a corresponding authorized basis, scaling to its goal of being Europe’s main distributor of medicinal hashish. The corporation presently distributes medical hashish to pharmacies in Germany given that March 2019 and is totally licenses in the Uk to start out distribution functions there in 2020. Farmako is a 100% subsidiary of AgraFlora Organics International Inc. For additional info make sure you check out: https://www.farmako-world wide.com/.
ON BEHALF OF THE BOARD OF Administrators
T: (800) 783-6056
For French inquiries:
T: (888) 585-MARI
The CSE and Info Services Supplier have not reviewed and does not settle for accountability for the precision or adequacy of this release.
Ahead-searching Information Cautionary Statement
Besides for statements of historic point this news launch contains certain “forward-wanting information” in just the meaning of relevant securities legislation. Forward-searching info is frequently characterised by words this kind of as “plan” “expect” “project” “intend” “believe” “anticipate” “estimate” and other similar words and phrases or statements that certain situations or conditions “may” or “will” happen. Ahead-searching statements are based mostly on the viewpoints and estimates at the date the statements are produced and are issue to a range of dangers and uncertainties and other aspects that could bring about genuine situations or effects to differ materially from all those anticipated in the forward-seeking statements including but not confined to delays or uncertainties with regulatory approvals including that of the CSE. There are uncertainties inherent in ahead-on the lookout data like elements outside of the Company’s control. There are no assurances that the business enterprise options for AgraFlora Organics explained in this news launch will arrive into effect on the terms or time frame explained herein. The Organization undertakes no obligation to update ahead-looking facts if conditions or management’s estimates or viewpoints must adjust besides as expected by law. The reader is cautioned not to put undue reliance on forward-searching statements. More info figuring out dangers and uncertainties that could impact money final results is contained in the Company’s filings with Canadian securities regulators which are readily available at www.sedar.com.